Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LORATADINE AND PSEUDOEPHEDRINE SULFATE

LORATADINE; PSEUDOEPHEDRINE SULFATE

Standard Dose
5MG;120MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview LORATADINE AND PSEUDOEPHEDRINE SULFATE is listed in Drugs@FDA under application 076208 (ANDA).

Marketing status: Discontinued Active ingredient LORATADINE; PSEUDOEPHEDRINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG;120MG Sponsor HERITAGE PHARMA Submission history Latest submission status date: 2004-11-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview LORATADINE AND PSEUDOEPHEDRINE SULFATE is listed in Drugs@FDA under application 076208 (ANDA). Marketing status: Discontinued Active ingredient LORATADINE; PSEUDOEPHEDRINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG;120MG Sponsor HERITAGE PHARMA Submission history Latest submission status date: 2004-11-26 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.